The very first bellwether trial for TRT lawsuits ended in a mistrial which involved a plaintiff whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to be paid as punitive damage by AbbVie to an Oregon man, under the claim of false marketing is big news that brings a lot of hope to the plaintiffs. Though the federal jury has not held AbbVie responsible for the alleged injury, this Chicago verdict can undoubtedly be considered as a strong signal to alert AbbVie and makes the battle turn positively towards the Plaintiffs. This verdict will now help thousands of TRT cases to move in the just and right direction. Neural IT has hands-on experience in medical reviews and can be a potential partner for law firms looking forward to litigating TRTs.
Recent News
Roundup Lawsuits in New Jersey Seek Centralization
03/04/2024 - 17:33
A request has been filed by a group of plaintiffs urging the consolidation of all Roundup lawsuits related to non-Hodgkin’s lymphom…
Learn More
Baltimore Settles in Walmart Opioid Cases
03/03/2024 - 20:48
The mayor of Baltimore, representing the City, has endorsed a statewide settlement with Walmart to address the corporation's allege…
Learn More
Opioid Crisis: Fentanyl and Meth Drive 'Fourth Wave…
02/27/2024 - 21:02
The United States is currently grappling with what some experts identify as the "fourth wave" of the opioid epidemic, presenting in…
Learn More
Oregon Re-evaluates Decriminalization Amid Opioid Crisis
02/20/2024 - 16:46
In 2020, Oregonians approved a groundbreaking ballot measure, known as Measure 110, establishing the most progressive drug law in t…
Learn More